Literature DB >> 32232577

Physiological and Lifestyle Traits of Metabolic Dysfunction in the Absence of Obesity.

Hanna Bjørk Klitgaard1, Jesper Hoffmann Kilbak1, Erica Arhnung Nozawa1, Ann V Seidel1, Faidon Magkos2.   

Abstract

PURPOSE OF REVIEW: Individuals with metabolically unhealthy normal weight (MUNW) have an adverse cardiometabolic risk factor profile in the absence of excess body weight, and increased risk for diabetes and heart disease. We critically review some physiological traits and lifestyle characteristics of the MUNW phenotype. RECENT
FINDINGS: The prevalence of MUNW varies considerably around the world and among ethnicities, partly because of different definitions; on average, this phenotype affects about ~ 30% of normal weight persons globally. Most studies have recruited MUNW subjects who, although within the normal weight range, are significantly "more obese" than their metabolically healthy lean peers (greater body mass index or total body fat); hence one cannot ascertain whether observed differences are true traits of the MUNW phenotype of simply secondary to greater relative adiposity within the normal range. Carefully matched studies have indicated that MUNW can exist in the absence of excess total body fat. These subjects have a preferential accumulation of fat in the upper body (abdominal subcutaneous and visceral adipose tissues) and the liver, but not skeletal muscle; perhaps surprisingly, this predominantly "android" fat distribution does not translate into increased waist circumference. The MUNW phenotype is associated with lower aerobic fitness and muscle mass and strength, but whether this is simply due to inadequate regular physical activity is not entirely clear. Likewise, no consistent associations have been found between any dietary factors and the development of MUNW phenotype, but diet-induced modest weight loss facilitates its resolution. Delineating the mechanisms leading to metabolic dysfunction in the absence of increased body weight and body fat will likely reveal important targets for improving metabolic health and eventually for reducing the burden of cardiometabolic disease, not only in individuals with normal body weight but also in people with obesity.

Entities:  

Keywords:  Body fat distribution; Cardiometabolic risk; Metabolic disease; Metabolically abnormal lean; Metabolically obese normal weight

Year:  2020        PMID: 32232577     DOI: 10.1007/s11892-020-01302-2

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  6 in total

Review 1.  Risk of Type 2 Diabetes Among Individuals with Excess Weight: Weight Trajectory Effects.

Authors:  Arthur H Owora; David B Allison; Xuan Zhang; Nana Gletsu-Miller; Kishore M Gadde
Journal:  Curr Diab Rep       Date:  2022-07-04       Impact factor: 5.430

2.  Metabolic and Obesity Phenotype Trajectories in Taiwanese Medical Personnel.

Authors:  Hsin-Yun Chang; Jer-Hao Chang; Yin-Fan Chang; Chih-Hsing Wu; Yi-Ching Yang
Journal:  Int J Environ Res Public Health       Date:  2022-07-04       Impact factor: 4.614

3.  Dissociation Between Insulin Resistance and Abnormalities in Lipoprotein Particle Concentrations and Sizes in Normal-Weight Chinese Adults.

Authors:  Kaare Tranæs; Cherlyn Ding; Yu Chung Chooi; Zhiling Chan; John Choo; Melvin K-S Leow; Faidon Magkos
Journal:  Front Nutr       Date:  2021-02-26

4.  The relationship between metabolic syndrome and obstructive sleep apnea syndrome: a nationwide population-based study.

Authors:  Do Hyun Kim; Bongseong Kim; Kyungdo Han; Soo Whan Kim
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.379

Review 5.  Intervertebral Disc and Adipokine Leptin-Loves Me, Loves Me Not.

Authors:  Goran Curic
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

6.  Lifestyle elements and risk of metabolic syndrome in adults.

Authors:  Edyta Suliga; Elzbieta Ciesla; Magdalena Lelonek; Agnieszka Piechowska; Stanislaw Gluszek
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.